Performance of calibration standards for antigen quantitation with flow cytometry in chronic lymphocytic leukemia

Cytometry Part B - Clinical Cytometry

Volumn 72, Issue 6, 2007, Pages 450-457

  Rossmann, Eva D ^a   Lenkei, Rodica ^b   Lundin, Jeanette ^a   Mellstedt, Håkan ^a   Österborg, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ST GÖRAN S HOSPITAL   (Sweden)

Author keywords

Calibration standards; CLL; Flow cytometry; Quantitative measurement of fluorescence intensity; Units of fluorescence intensity

Indexed keywords

CD20 ANTIGEN; CD4 ANTIGEN; NANOBEAD;

ADULT; AGED; ANTIGEN BINDING; ANTIGEN DETECTION; ARTICLE; CALIBRATION; CANCER PATIENT; CHRONIC LYMPHATIC LEUKEMIA; CONJUGATE; CONTROLLED STUDY; DEVICE; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; STANDARDIZATION; T LYMPHOCYTE;

ADULT; AGED; ANTIGENS, CD20; ANTIGENS, CD22; ANTIGENS, CD3; ANTIGENS, CD4; B-LYMPHOCYTES; CALIBRATION; CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MICROSPHERES; MIDDLE AGED; T-LYMPHOCYTES;

EID: 36049049473     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20359     Document Type: Article

References (42)

1. Lenkei R, Gratama JW, Rothe G, Schmitz G, D'Hautcourt JL, Arekrans A, Mandy F, Marti G. Performance of calibration standards for antigen quantitation with flow cytometry. Cytometry 1998;33:188-196.
2. Schmitz G, Rothe G, Ruf A, Barlage S, Tschope D, Clemetson KJ, et al. European Working Group on clinical cell analysis: Consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost 1998;79:885-896.
3. Liu Z, Hultin LE, Cumberland WG, Hultin P, Schmid I, Matud JL, et al. Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: Results of 6 years of follow-up. Cytometry 1996;26:1-7.
4. Liu Z, Cumberland WG, Hultin LE, Prince HE, Detels R, Giorgi JV. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the multicenter AIDS cohort study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:83-92.
5. Caldwell CW, Patterson WP. Relationship between CD45 antigen expression and putative stages of differentiation in B-cell malignancies. Am J Hematol 1991;36:111-115.
6. Matutes E, Catovsky D. The value of scoring systems for the diagnosis of biphenotypic leukemia and mature B-cell disorders. Leuk Lymphoma 1994;13 (Suppl 1):11-14.
7. Lavabre-Bertrand T, Duperray C, Brunet C, Poncelet P, Exbrayat C, Bourquard P, et al. Quantification of CD24 and CD45 antigens in parallel allows a precise determination of B-cell maturation stages: Relevance for the study of B-cell neoplasias. Leukemia 1994;8:402-408.
8. Lavabre-Bertrand T, Janossy G, Ivory K, Peters R, Seeker-Walker L, Porwit-MacDonald A. Leukemia-associated changes identified by quantitative flow cytometry: I. CD10 expression. Cytometry 1994;18:209-217.
9. Lavabre-Bertrand T, George F, Brunet C, Sampol J. Quantitative immune phenotyping: A new dimension for the monitoring of haemopoietic malignancies. Nouv Rev Fr Hematol 1994;36:373-382.
10. Babusikova O, Glasova M, Stasakova J, Kusenda J, Konikova E. Quantitative immunocytofluorometry - New parameters for the definition of leukemia cells. Neoplasma 1997;44:348-355.
11. Glasova M, Konikova E, Stasakova J, Babusikova O. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells. Neoplasma 1998;45:88-95.
12. Atra A, Abboudi Z, Farahat N, Catovsky D. Quantitative flow cytometry can predict childhood acute lymphoblastic leukaemia presenting with aplasia. Leuk Lymphoma 1997;27:173-177.
13. Lavabre-Bertrand T. Flow-cytometric quantitation in chronic leukemias. Eur J Histochem 1996;40 (Suppl 1):33-38.
14. Matutes E, Owusu-Ankomah K, Morula R, Garcia Marco J, Houlihan A, Que TH, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994;8:1640-1645.
15. Batata A, Shen B. Immunophenotyping of subtypes of B-chronic (mature) lymphoid leukemia. A study of 242 cases. Cancer 1992;70:2436-2443.
16. Robbins BA, Ellison DJ Spinosa JC, Carey CA, Lukes RJ, Poppema S, et al. Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood 1993;82:1277-1287.
17. Geisler CH, Larsen JK, Hansen NE, Hansen MM, Christensen BE, Lund B, et al. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood 1991;78:1795-1802.
18. Molica S, Levato D, Dattilo A, Mannella A. Clinico-prognostic relevance of quantitative immunophenotyping in B-cell chronic lymphocytic leukemia with emphasis on the expression of CD20 antigen and surface immunoglobulins. Eur J Haematol 1998;60:47-52.
19. Tefferi A, Bartholmai BJ, Witzig TE, Li CY, Hanson CA, Phyliky RL. Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemia. Am J Clin Pathol 1996;106:457-461.
20. Schwartz A, Marti GE, Poon R, Gratama JW, Fernandez-Repollet E. Standardizing flow cytometry: A classification system of fluorescence standards used for flow cytometry. Cytometry 1998;33:106-114.
21. Schwartz A, Fernandez-Repollet E. Immunophenotyping. New York: Wiley-Liss; 2000.
22. NCCLS EG. Fluorescence calibration and quantitative measurement of fluorescent intensity. Proposed Guideline 2005;23(31).
23. Iyer SB, Bishop JE, Abrams B, Maino VC, Ward AJ, Christian TP, et al. QuantiBRITE: A new standard for fluorescence quantitation. In: Systems BDI. 1997. pp 23-3496.
24. Lundin J, Kimby E, Bergmann L, Karakas T, Mellstedt H, Osterborg A. Interleukin 4 therapy for patients with chronic lymphocytic leukaemia: A phase I/II study. Br J Haematol 2001;112:155-160.
25. Rossmann ED, Lundin J, Lenkei R, Mellstedt H, Osterborg A. Variability in B-cell antigen expression: Implications for the treatment of B-cell lymphomas and leukemias with monoclonal antibodies. Hematol J 2001;2:300-306.
26. Marti GE, Faguet G, Bertin P, Agee J, Washington G, Ruiz S, et al. CD20 and CD5 expression in B-chronic lymphocytic leukemia. Ann NY Acad Sci 1992;651:480-483.
27. Almasri NM, Duque RE, Iturraspe J, Everett E, Braylan RC. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia. Am J Hematol 1992;40:259-263.
28. Lavabre-Bertrand T, Poncelet P. Antigen density in B-cell chronic lymphocytic leukemia. Am J Clin Pathol 1995;103:375.
29. Marti G. Quantitative FLow Cytometry (QFCM) in B-Chronic Lymphocytic Leukemia (B-CLL). Clin Immunol Newslett 1995;15(6/7):82-87.
30. Werlen G, Palmer E. The T-cell receptor signalosome: A dynamic structure with expanding complexity. Curr Opin Immunol 2002;3:299-305.
31. Schwartz A, Fernandez Repollet E, Vogt R, Gratama JW. Standardizing flow cytometry: Construction of a standardized fluorescence calibration plot using matching spectral calibrators. Cytometry 1996;26:22-31.
32. Schwartz A, Ottinger J, Wallace E, Poon R, Fernandez-Repollet E. Quantitative determination of antibody binding capacity (ABC) by flow cytometry. Eur J Histochem 1994;38 (Suppl 1):13-20.
33. Lin SJ, Chao HC, Yan DC, Huang YJ. Expression of adhesion molecules on T lymphocytes in young children and infants - A comparative study using whole blood lysis or density gradient separation. Clin Lab Haematol 2002;24:353-359.
34. Barnett D, Storie I, Wilson GA, Granger V, Reilly JT. Determination of leucocyte antibody binding capacity (ABC): The need for standardization. Clin Lab Haematol 1998;20:155-164.
35. Vogt R, Marti G, Schwartz A. Quantitative calibration of fluorescence intensity for clinical and research applications of immunophenotyping by flow cytometry. Review of Biotechnology and Bioengineering, Cytometry 1994; p 302-306.
36. Shapiro. Practical Flow Cytometry, 3rd ed. New York: Wiley-Liss; 1995.
37. Serke S, van Lessen A, Huhn D. Quantitative fluorescence flow cytometry: A comparison of the three techniques for direct and indirect immunofluorescence. Cytometry 1998;33:179-187.
38. Bikoue A, George F, Poncelet P, Mutin M, Janossy G, Sampol J. Quantitative analysis of leukocyte membrane antigen expression: Normal adult values. Cytometry 1996;26:137-147.
39. Davis KA, Abrams B, Iyer SB, Hoffman RA, Bishop JE. Determination of CD4 antigen density on cells: Role of antibody valency, avidity, clones, and conjugation. Cytometry 1998;33:197-205.
40. Gratama JW, D'Hautcourt JL, Mandy F, Rothe G, Barnett D, Janossy G, et al. Flow cytometric quantitation of immunofluorescence intensity: Problems and perspectives. European Working Group on Clinical Cell Analysis. Cytometry 1998;33:166-178.
41. Bikoue A, Janossy G, Barnett D. Stabilised cellular immuno-fluorescence assay: CD45 expression as a calibration standard for human leukocytes. J Immunol Methods 2002;266:19-32.
42. Lenkei R, Andersson B. Determination of the antibody binding capacity of lymphocyte membrane antigens by flow cytometry in 58 blood donors. J Immunol Methods 1995;183:267-277.